← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Akston Biosciences Corporation
Beverly, MA
$4,399,153
Total funding
3
Grants
Funding over time
peak $999K · FY2014–20$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$4,399,153 · 3
By mechanism
R44$3,899,406 · 1
R43$499,747 · 2
Investigators at Akston Biosciences Corporation
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Selective Depletion of Insulin-Specific B cells to Prevent Type 1 Diabetes$998,998
R44 · FY2018 · DK
Selective Depletion of Insulin-Specific B cells to Prevent Type 1 Diabetes$998,123
R44 · FY2017 · DK
IND-enabling assay validation and toxicology studies on AKS-107: a novel antigen-specific B cell therapeutic to prevent Type 1 Diabetes$978,643
R44 · FY2019 · DK
IND-enabling assay validation and toxicology studies on AKS-107: a novel antigen-specific B cell therapeutic to prevent Type 1 Diabetes$923,642
R44 · FY2020 · DK
Novel Compounds for Reducing Brain A-Beta Levels via Enhanced Systemic Clearance$249,926
R43 · FY2014 · AG
Selective Removal of Insulin-Specific B-cells to Prevent Type I Diabetes in NOD Mice$249,821
R43 · FY2015 · DK